A team of researchers at University of Texas at Austin’s Institute of Biomaterials, Drug Delivery, and Regenerative Medicine is working to develop a pill to treat hemophilia B. This pill in the making is expected to be a breakthrough in the treatment of hemophilia B since it will put an end to the administration of weekly injections.
